文献速递血液透析通路

较高体重指数与上肢动静脉通路建立后再次干预及成熟率降低相关

Higher body mass index is associated with reinterventions and lower maturation rates after upper extremity arteriovenous access creation.
PubMed 文献 · J Vasc Surg · 2020-05-19

一项单中心回顾性研究纳入2014至2018年611例上肢动静脉通路建立患者,按体重指数分为正常体重、超重、肥胖和重度肥胖组。结果显示肥胖与180天内成熟失败风险升高及再次干预风险增加独立相关,但与远期再入院或生存无关。

要点

  • 超重、肥胖和重度肥胖患者180天内动静脉通路成熟失败风险显著高于正常体重者。
  • 超重、肥胖和重度肥胖患者再次干预风险较正常体重者升高。
  • 为肥胖患者建立血管通路时应考虑成熟失败风险并调整预期。

核心结论

  • 肥胖与上肢动静脉通路成熟失败率升高及再次干预风险增加相关。

研究设计与样本

  • 回顾性单中心研究,纳入2014至2018年611例上肢动静脉通路建立患者。

主要发现

  • 180天内通路成熟率:正常体重74.3%、超重66%、肥胖65.7%、重度肥胖46.6%(P < .001)。
  • 2年免于再次干预率:正常体重44.5% ± 4.6%、超重29% ± 3.8%、肥胖39.8% ± 4.3%、重度肥胖34.7% ± 8%(P = .041)。
  • 多变量分析中,180天内成熟失败与超重(OR 1.93,95%CI 1.14-3.29,P = .002)、肥胖(OR 2.12,95%CI 1.19-3.47,P = .009)和重度肥胖(OR 3.68,95%CI 1.85-7.3,P < .001)相关。
  • 再次干预与超重(HR 1.83,95%CI 1.34-2.5)、肥胖(HR 1.56,95%CI 1.12-2.16)和重度肥胖(HR 1.69,95%CI 1.1-2.58,P = .02)相关。
  • BMI与远期再入院或生存无独立关联。

临床怎么用

  • 为肥胖患者规划动静脉通路时应告知成熟失败和再次干预风险较高。
  • 可考虑将减重辅助纳入肥胖患者的治疗流程。

局限性

  • 回顾性单中心设计可能限制结论外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A patient's body mass index (BMI) can affect both perioperative and postoperative outcomes across all surgical specialties. Given that obesity and end-stage renal disease are growing in prevalence, we aimed to evaluate the association between BMI and outcomes of upper extremity arteriovenous (AV) access creation. METHODS: A retrospective single-institution review was conducted for AV access creations from 2014 to 2018. Patient demographics, comorbidities, and AV access details were recorded. BMI groups were defined as normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), obese (30-39.9 kg/m2), and morbidly obese (>40 kg/m2). Perioperative complications and long-term outcomes including access maturation (defined as access being used for hemodialysis or the surgeon's judgment that access was ready for use in patients not yet on hemodialysis), occlusion, and reintervention were evaluated. RESULTS: A total of 611 upper extremity AV access creations were performed on patients who were normal weight (29.6%), overweight (31.3%), obese (29.6%), and morbidly obese (9.5%). Access type included brachiocephalic (43.2%), brachiobasilic (25.5%), and radiocephalic (14.2%) fistulas and AV grafts (14.2%). Median age was 60.9 years, and 59.6% were male. Univariable analysis showed no difference between BMI groups for perioperative steal, hematoma, home discharge, or 30-day primary patency. Freedom from reintervention at 2 years on Kaplan-Meier analysis differed by BMI (44.5% ± 4.6% normal weight, 29% ± 3.8% overweight, 39.8% ± 4.3% obese, 34.7% ± 8% morbidly obese; P = .041). There was no difference in 2-year freedom from new access creation or survival. AV access maturity within 180 days differed between BMI groups (74.3% normal weight, 66% overweight, 65.7% obese, 46.6% morbidly obese; P < .001). On multivariable analysis, failure to mature within 180 days was associated with overweight (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.14-3.29; P = .002), obese (OR, 2.12; 95% CI, 1.19-3.47; P = .009), and morbidly obese (OR, 3.68; 95% CI, 1.85-7.3; P < .001) relative to normal weight BMI. AV access reintervention was associated with overweight (hazard ratio [HR], 1.83; 95% CI, 1.34-2.5), obese (HR, 1.56; 95% CI, 1.12-2.16), and morbidly obese (HR, 1.69; 95% CI, 1.1-2.58; P = .02) relative to normal weight BMI. BMI was not independently associated with long-term readmission or survival. CONCLUSIONS: Obesity is associated with higher rates of AV access failure to mature and reintervention. Surgeons performing access creation on obese patients must consider this for planning and setting expectations. Weight loss assistance may need to be incorporated into treatment algorithms.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Raulli SJ, Sather K, Dicken QG, et al. Higher body mass index is associated with reinterventions and lower maturation rates after upper extremity arteriovenous access creation. J Vasc Surg. 2020. PMID: 32442609. doi:10.1016/j.jvs.2020.04.510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。